Health Canada Approves BOTOX as Prophylactic Treatment for Chronic Migraine

Symbols: AGN
Posted in: News, FDA
Share

Chronic Migraine sufferers in Canada now have an option to prevent the onset of headaches that occur over 15 days a month and leave patients debilitated. Health Canada has approved BOTOX® (onabotulinumtoxinA) manufactured by Allergan, Inc. as a prophylactic (preventive) treatment for headaches in adult patients with Chronic Migraine who suffer from headaches 15 days or more per month, lasting four hours a day or longer.1


 
 
< Previous
Rodman & Renshaw Reiterates Outperform on Cytori Therapeutics As Sales Grow Slowly
Next >
MoneyGram International Announces Reverse Stock Split
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust